Eurobio-Scientific

What Eurobio-Scientific does

Eurobio-Scientific is a French specialty diagnostics company, publicly traded on Euronext Paris (ticker ALXP) and headquartered in Les Ulis, France. The company develops, manufactures, and distributes in vitro diagnostic (IVD) products across four therapeutic verticals: Transplantation (GenDx HLA typing reagents and chimerism monitoring kits), Oncology (EndoPredict breast cancer genomic test, Prolaris prostate cancer test, and companion diagnostic services), Infectious Diseases (EurobioPlex real-time PCR kits and TECO FungiLine rapid fungal diagnostics), and Life Sciences (cell culture media, ELISA kits, molecular biology reagents, and immunology antibodies). Core technologies span PCR, next-generation sequencing, ELISA, lateral flow assays, and corneal organoculture media, with manufacturing operations in France (Les Ulis) and the Netherlands (Utrecht).

The business operates a hybrid revenue model combining proprietary product sales — representing approximately 35% of FY2025 revenue — with distribution of third-party diagnostic products (Seegene multiplex PCR, ABL Diagnostics, CareDx products pre-acquisition) through owned subsidiaries and channel partners. Approximately 42% of sales are generated outside France. The customer base spans transplant centers and HLA laboratories, hospital systems, clinical pathology laboratories, and life sciences researchers, served through direct enterprise sales for specialized products (HLA typing, oncology) and an extensive distributor network built through over 50 acquisitions. Distribution is concentrated in Europe (France, Italy, Netherlands, Germany, UK, Switzerland, Austria, Belgium) with North American and Oceania operations.

Recent strategic activity has been heavily acquisition-driven, with the €135 million GenDx acquisition in 2022 establishing proprietary transplantation diagnostics, the 2023 DID acquisition anchoring Italian IVD distribution, the 2025 Voden/Quimark Italian consolidation, and a pending $170 million acquisition of CareDx's Lab Products division announced in April 2026. The company holds CE-IVD, ISO 13485, and ISO 9001 certifications across multiple entities and operates in more than 10 countries through owned affiliates.

Name

Eurobio-Scientific

Legal name

Eurobio Scientific

Website

https://www.eurobio-scientific.com/

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Eurobio-Scientific is a French specialty diagnostics company that develops, manufactures, and distributes in vitro diagnostic products across transplantation, oncology, infectious diseases, and life sciences, serving transplant centers, clinical laboratories, and hospital systems in more than 10 countries through proprietary products and an acquired distribution network.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

Keywords

• In vitro diagnostics
• Molecular diagnostics
• HLA typing
• Transplant diagnostics
• Specialty diagnostics

Headquarters

HQ city

Essonnes

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Others

Revenue model

1. Product Sales - IVD and Diagnostic Instruments: Sale of in vitro diagnostic instruments, reagents, and test kits directly to laboratories, hospitals, and transplant centers. Revenue generated from proprietary diagnostic products and distributed branded products.
2. Distribution Revenue: Revenue from distributing third-party diagnostic products through acquired distributor networks in Italy and other regions, earning margins on resale of products from partners including Seegene and ABL Diagnostics.
3. Acquisition Integration - Regional Expansion: Revenue growth driven by strategic acquisitions of diagnostic distributors (DID Italy, Quimark SRL, Voden Medical Instruments), expanding geographic footprint and customer base across European markets.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Eurobio-Scientific develops, manufactures, and distributes specialty in vitro diagnostic (IVD) products for clinical laboratories, hospitals, and transplant centers across four areas: transplantation (HLA typing kits, chimerism monitoring, cornea preservation media), oncology (EndoPredict breast cancer and Prolaris prostate cancer genomic tests), infectious diseases (multiplex PCR kits, fungal antigen assays), and life sciences (cell culture media, ELISA kits, molecular biology reagents). The company also offers companion diagnostic development services and distributes third-party IVD brands through acquired regional affiliates in Europe, North America, and Asia-Pacific.

Product overview

Eurobio Scientific is a specialty diagnostics company that develops, produces, and distributes in vitro diagnostic products for clinical use. The portfolio comprises proprietary and distributed products across four main therapeutic areas: Transplantation (GenDx HLA typing and chimerism monitoring reagents with NGSengine/KMRengine analysis software, plus cornea preservation media), Oncology (EndoPredict breast cancer and Prolaris prostate cancer genomic tests, plus companion diagnostic development services), Infectious Diseases (EurobioPlex real-time PCR kits for respiratory/vector-borne infections, TECO FungiLine rapid fungal diagnostics, and TQS tetanus rapid tests), and Life Sciences (cell culture media, PKA biosafety assays, ELISA kits, molecular biology reagents, immunology antibodies, and PathTROL quality controls). The company operates manufacturing sites in France (Les Ulis) and the Netherlands (Utrecht), with distribution across more than 10 countries through local affiliates.

Differentiator

Problem solved

Functional benefit

Brands

• EndoPredict: Genomic test for breast cancer prognosis and chemotherapy benefit prediction for ER-positive, HER2-negative early-stage breast cancer
• Prolaris
• GenDx
• EurobioPlex
• TECO
• PathTROL
• CorneaMax/CorneaPrep
• DID (Diagnostic International Distribution)

Products and services

• GenDx Product Portfolio Proprietary molecular diagnostic product portfolio for transplantation including NGS-based HLA typing reagents (NGSgo, NGS-Turbo, NGSgo-AmpX, NGSgo-MX6-1, NGSgo-MX11-3, NGSgo-ProntoFLX, NGSgo-ProntoAmp), chimerism monitoring kits (KMRtype, KMRtrack, NGStrack), and analysis software (NGSengine, KMRengine, TRKengine) for transplant matching and post-transplant surveillance. Sold to transplant centers and HLA laboratories.
• Cornea Product Portfolio

Quantifiable outcome

• GenDx acquisition for €135 million represents company's largest transaction, expanding molecular diagnostics capabilities
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• CareDxcoreChannel Partner/ Reseller/ Distributor · 3 October 2022Acquisition of CareDx's Lab Products division by Eurobio Scientific, including the KMRtract and KMRtype product lines for transplantation diagnostics. CareDx received €42 million initial payment plus additional earnout. Eurobio Scientific gained full ownership of transplantation testing products previously distributed through GenDx.
• GenDxcoreTechnology or Integration · 3 October 2022GenDx, acquired for €135 million, is a leader in molecular diagnostics for transplantation (HLA typing). The acquisition provided Eurobio Scientific with proprietary NGS-based HLA typing technology and established the company as a leader in transplantation molecular diagnostics in Europe.
• DID (Diagnostic International Distribution)coreChannel Partner/ Reseller/ DistributorAcquisition of DID, a leading Italian diagnostic distribution company, expanding Eurobio Scientific's presence in the Italian market. DID had been a long-standing distributor for Eurobio products and other major in vitro diagnostics manufacturers.
• Quimark SRLminorChannel Partner/ Reseller/ DistributorAcquisition of Quimark SRL, an Italian diagnostic distributor specializing in immunology and molecular diagnostics products. Expansion of Italian subsidiary operations.
• Voden Medical Instruments SpacoreChannel Partner/ Reseller/ DistributorAcquisition of Voden Medical Instruments Spa, based in Lodi, Italy, further expanding Eurobio Scientific's Italian distribution network and customer base in clinical diagnostics.
• SeegenecoreTechnology or IntegrationStrategic partnership with South Korean molecular diagnostics company Seegene for distribution of Seegene's multiplex PCR-based diagnostic products. Seegene provides proprietary molecular diagnostics technology including automated sample preparation and syndromic testing panels.
• ABL DiagnosticsminorChannel Partner/ Reseller/ DistributorDistribution agreement with ABL Diagnostics for infectious disease diagnostic products. Eurobio Scientific distributes ABL Diagnostics' molecular diagnostic assays for infectious diseases through its European distribution network.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• bioMérieux: Global leader in in vitro diagnostics headquartered in France, with a broad microbiology and molecular diagnostics portfolio. Directly comparable to Eurobio as a French-headquartered IVD specialist and a likely benchmark for European specialty diagnostics multiples.
• QIAGEN: Global molecular diagnostics and sample technologies leader with deep presence in PCR, HLA/ transplantation workflows, and infectious disease. Comparable to Eurobio's GenDx transplant and EurobioPlex infectious disease PCR lines, though at much larger scale.
• Hologic: US diagnostics and women's health company with a large molecular diagnostics franchise (Panther platform, Aptima assays). Comparable to Eurobio's infectious disease PCR portfolio in scale of molecular content and customer base.

Direct peers

• DiaSorin: Italian-headquartered specialty IVD company focused on immunodiagnostics and molecular diagnostics with strong European distribution. Comparable to Eurobio in European specialty IVD positioning, scale, and proprietary-plus-distribution business model.
• Seegene: South Korean molecular diagnostics company specializing in multiplex syndromic PCR testing. Direct partner and content supplier to Eurobio; comparable multiplex PCR technology competes in the same infectious disease menu space as EurobioPlex.
• CareDx: US-based transplant diagnostics specialist whose Lab Products division Eurobio is acquiring for $170M. Highly comparable in transplant HLA typing and chimerism monitoring, and will continue to overlap in post-transplant monitoring where CareDx retains North American rights.
• Immucor: Transfusion and transplantation diagnostics company specializing in HLA typing and blood banking reagents. Directly comparable to GenDx in transplant HLA and chimerism testing, and competes for the same transplant-center customers as Eurobio's GenDx line.
• ELITech Group: European specialty IVD company with broad chemistry, immunoassay, and molecular diagnostics menus distributed via local affiliates. Comparable to Eurobio in mid-size European specialty IVD positioning and channel-partner-led commercial model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCF2l7HqtnBl0dpYdxViKB5g
• LinkedInlinkedin.com/company/eurobio-scientific-group
• Xx.com/eurobiosc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries14 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A9 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurobio-Scientific